Amira A Helwa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Cell Cycle Arrest

Breast Cancer Cells

Vascular Endothelial Growth Factor

Top Venues

RSC medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Ghada S Rady, Moshira A El Deeb, Marwa T M Sarg, Azza T Taher, Amira A Helwa
Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors. RSC medicinal chemistry 15 (2) (2024)
Ghada S Rady, Moshira A El Deeb, Marwa T M Sarg, Azza T Taher, Amira A Helwa
Design, synthesis and biological evaluation of novel morpholinopyrimidine-5-carbonitrile derivatives as dual PI3K/mTOR inhibitors. RSC medicinal chemistry 15 (2) (2024)
Ahmed M Abdelhamed, Rasha A Hassan, Hanan H Kadry, Amira A Helwa
Novel pyrazolo[3,4- d ]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity. RSC medicinal chemistry 14 (12) (2023)
Ahmed M Abdelhamed, Rasha A Hassan, Hanan H Kadry, Amira A Helwa
Novel pyrazolo[3,4- d ]pyrimidine derivatives: design, synthesis, anticancer evaluation, VEGFR-2 inhibition, and antiangiogenic activity. RSC medicinal chemistry 14 (12) (2023)
Nada Reda, Ahmed Elshewy, Hesham I El-Askary, Khaled O Mohamed, Amira A Helwa
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives as novel anti-cancer, dual EGFR WT /COX-2 inhibitors with docking studies. RSC advances 13 (46) (2023)